Differential expression of versican isoforms in brain tumors

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 5, 1996, Pages 528-533

  Paulus, Werner ^a   Baur, Inge ^a   Dours Zimmermann, María T ^b   Zimmermann, Dieter R ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Astrocytoma; Extracellular matrix; Glycosaminoglycans; Meningioma; Proteoglycans; Schwannoma; Versican

Indexed keywords

PROTEOCHONDROITIN SULFATE; VERSICAN;

ARTICLE; ASTROCYTOMA; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENINGIOMA; NEURILEMOMA; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION;

EID: 0029874902     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199605000-00005     Document Type: Article

References (39)

1. Bignami A, Asher R, Perides G. Brain extracellular matrix and nerve regeneration. Adv Exp Med Biol 1991;296:197-206
2. Lander AD. Proteoglycans in the nervous system. Curr Opin Neurobiol 1993;3:716-23
3. Pilkington GJ. Tumour cell migration in the central nervous system. Brain Pathol 1994;4:157-66
4. Paulus W, Tonn JC. Interactions of glioma cells and extracellular matrix. J Neuro-Oncol 1995;24:87-91
5. Yung WK. New approaches to molecular therapy of brain tumors. Curr Opin Neurol 1994;7:501-5
6. Jaeckle KA. Immunotherapy of malignant gliomas. Semin Oncol 1994;21:249-59
7. Zimmermann DR, Ruoslahti E. Multiple domains of the large fibroblast proteoglycan, versican. EMBO J 1989;8:2975-81
8. Shinomura T, Nishida Y, Ito K, Kimata K. cDNA cloning of PG-M, a large chondroitin sulfate proteoglycan expressed during chondrogenesis in chick limb buds. Alternative spliced multiforms of PG-M and their relationships to versican. J Biol Chem 1993;268: 14461-69
9. Margolis RU, Margolis RK. Aggrecan-versican-neurocan family proteoglycans. Methods Enzymol 1994;245:105-26
10. Doege K, Sasaki M, Horigan E, Hassell JR, Yamada Y. Complete primary structure of the rat cartilage proteoglycan core protein deduced from cDNA clones. J Biol Chem 1987;262.17757-67
11. Rauch U, Karthikeyan L, Maurel P, Margolis RU, Margolis RK. Cloning and primary structure of neurocan, a developmentally regulated, aggregating chondroitin sulfate proteoglycan of brain. J Biol Chem 1992;267:19536-47
12. Yamada H, Watanabe K, Shimonaka M, Yamaguchi Y. Molecular cloning of brevican, a novel brain proteoglycan of the aggrecan/ versican family. J Biol Chem 1994;269:10119-26
13. Dours-Zimmermann MT, Zimmermann DR. A novel glycosaminoglycan attachment domain identified in two alternative splice variants of human versican. J Biol Chem 1994;269:32992-98
14. Bode-Lesniewska B, Dours-Zimmermann MT, Odermatt BF, Briner J, Heitz PU, Zimmermann DR. Distribution of the large aggregating proteoglycan versican in adult human tissues. J Histochem Cytochem, in press
15. Naso MF, Zimmermann DR, Iozzo RV. Characterization of the complete genomic structure of the human versican gene and functional analysis of its promoter. J Biol Chem 1994;269:32999-33008
16. Ito K, Shinomura T, Zako M, Ujita M, Kimata K. Multiple forms of mouse PG-M, a large chondroitin sulfate proteoglycan generated by alternative splicing. J Biol Chem 1995;270:958-65
17. Zako M, Shinomura T, Ujita M, Ito K, Kimata K. Expression of PG-M (V3), an alternatively spliced form of PG-M without a chondroitin sulfate attachment region in mouse and human tissues. J Biol Chem 1995;270:3914-18
18. Crawford TJ, Melhado IG, Jink FR. Expression of versican mRNA is developmentally regulated in the brain of the embryonic chick and the developing rat. Dev Brain Res 1993;76:264-67
19. Bignami A, Perides G, Rahemtulla E Versican, a hyaluronate-binding proteoglycan of embryonal precartilaginous mesenchyma, is mainly expressed postnatally in rat brain. J Neurosci Res 1993;34.97-106
20. Yamagata M, Suzuki S, Akiyama SK, Yamada KM, Kimata K. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates. J Biol Chem 1989;264:8012-18
21. Yamagata M, Saga S, Kato M, Bernfield M, Kimata K. Selective distributions of proteoglycans and their ligands in pericellular matrix of cultured fibroblasts. Implications for their roles in cellsubstratum adhesion. J Cell Sci 1993;106:55-65
22. Landolt RM, Vaughan L, Winterhalter KH, Zimmermann DR. Versican is selectively expressed in embryonic tissues that act as barriers to neural crest cell migration and axon outgrowth. Development 1995;121:2303-12
23. Zimmermann DR, Dours-Zimmermann MT, Schubert M, Bruckner-Tuderman L. Versican is expressed in the proliferating zone in the epidermis and in association with the elastic network of the dermis. J Cell Biol 1994;124:817-25
24. Romans M, Villena J, Molist A, Heredia A, Bassols A. Ras transformation alters the composition of extracellular matrix proteogly-cans in rat fibroblasts. Biochem Biophys Res Commun 1994;200: 925-32
25. Kleihues P, Burger PC, Scheithauer BW. Histological typing of tumours of the central nervous system, 2nd ed. Berlin: Springer, 1993
26. Celio MR, Blümcke I. Perineuronal nets - A specialized form of extracellular matrix in the adult nervous system. Brain Res Rev 1994;19:128-45
27. Perides G, Asher RA, Lark MW, Lane WS, Robinson RA, Bignami A. Glial hyaluronate-binding protein: A product of metalloproteinase digestion of versican? Biochem J 1995;312:377-84
28. Engelhardt A. Detection of acid mucopolysaccharides in human brain tumors by histochemical methods. Acta Neuropathol 1980;49: 199-203
29. Bock P, Jellinger K. Detection of glycosaminoglycans in human gliomas by histochemical methods. Acta Neuropathol 1981;Suppl VII: 81-84
30. Bertolotto A, Goia L, Schiffer D. Immunohistochemical study of chondroitin sulfate in human gliomas. Acta Neuropathol 1986;72: 189-96
31. Nioka H, Matsumura K, Nakasu S, Handa J. Immunohistochemical localization of glycosaminoglycans in experimental rat glioma models. J Neuro-Oncol 1994;21:233-42
32. Bertolotto A, Giordana MT, Orsi L, Orsi R, Schiffer D. Biochemical, histochemical and immunohistochemical study of glycosaminoglycans in human meningiomas. Basic Appl Histochem 1989;33: 239-49
33. Paulus W, Sage EH, Liszka U, Iruela-Arispe ML, Jellinger K. Increased levels of type VIII collagen in human brain tumours compared to normal brain tissue and non-neoplastic cerebral disorders. Br J Cancer 1991;63:367-71
34. Higuchi M, Ohnishi T, Arita N, Hiraga S, Hayakawa T. Expression of tenascin in human gliomas: Its relation to histological malignancy, tumor dedifferentiation and angiogenesis. Acta Neuropathol 1993;85:481-87
35. Zagzag D, Friedlander DR, Miller DC, et al. Tenascin expression in astrocytomas correlates with angiogenesis. Cancer Res 1995;55: 907-14
36. Schrappe M, Klier FG, Spiro RC, Waltz TA, Reisfeld RA, Gladson CL. Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. Cancer Res 1991;51:4986-93
37. 131I-labeled anti-tenascin monoclonal antibody 81C6. Cancer Res 1988;48:2904-10
38. Schrappe M, Bumol TF, Apelgren LD, et al. Long-term growth suppression of human glioma xenografts by chemoimmunoconjugates of 4-desacetylvinblastine-3-carboxyhydrazide and monoclonal antibody 9.2.27. Cancer Res 1992;52:3838-44
39. Riva P, Arista A, Tison V, et al. Intralesional radioirnmunotherapy of malignant gliomas. An effective treatment in recurrent tumors. Cancer 1994;73(Suppl 3): 1076-82